BRIEF published on 07/08/2025 at 22:15, 8 months 14 days ago GENFIT Reports on Half-Year Liquidity Contract with Crédit Industriel et Commercial Biopharmaceutical Liver Diseases Crédit Industriel GENFIT Liquidity 2025 Trading
BRIEF published on 07/08/2025 at 22:15, 8 months 14 days ago GENFIT annonce son contrat de liquidité semestriel avec le Crédit Industriel et Commercial Biopharmaceutique Crédit Industriel Maladies Du Foie Liquidité De GENFIT Négociations 2025
PRESS RELEASE published on 07/08/2025 at 22:10, 8 months 14 days ago Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, detailing trading activities and resources as of June 30, 2025 Liquidity Contract Financial Report Crédit Industriel Et Commercial Trading Activities GENFIT
PRESS RELEASE published on 07/08/2025 at 22:10, 8 months 14 days ago Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial GENFIT annonce le bilan semestriel de son contrat de liquidité avec le Crédit Industriel et Commercial, incluant les transactions et moyens de liquidité au 30 juin 2025 Contrat De Liquidité Bilan Semestriel Transactions Crédit Industriel Et Commercial GENFIT
BRIEF published on 06/17/2025 at 20:35, 9 months 5 days ago L'Assemblée Générale de GENFIT approuve les résolutions du Conseil d'Administration Resolutions Produits Biopharmaceutiques Assemblée Générale Des Actionnaires GENFIT Maladies Du Foie
BRIEF published on 06/17/2025 at 20:35, 9 months 5 days ago GENFIT's Shareholder Meeting Approves Board's Resolutions Biopharmaceuticals Resolutions Liver Diseases Shareholders Meeting GENFIT
PRESS RELEASE published on 06/17/2025 at 20:30, 9 months 5 days ago GENFIT: June 17, 2025 Combined Shareholders Meeting Results GENFIT announces approval of all resolutions at June 17, 2025 Combined Shareholders Meeting. Exception: resolution n°28 rejected. Quorum: 27.21% Resolutions Approval Quorum Shareholders Meeting GENFIT
PRESS RELEASE published on 06/17/2025 at 20:30, 9 months 5 days ago GENFIT : Résultats de l’Assemblée Générale Mixte du 17 juin 2025 GENFIT annonce les résultats de son Assemblée Générale Mixte du 17 juin 2025, approuvés avec un quorum de 27,21%, tout en dévoilant sa mission et activités dans le secteur biopharmaceutique Biopharmaceutique Assemblée Générale Mixte Maladies Rares GENFIT Foie
BRIEF published on 05/22/2025 at 22:15, 10 months ago GENFIT: First Quarter 2025 Financial Results Treasury Royalties GENFIT Iqirvo® Clinical Phase
BRIEF published on 05/22/2025 at 22:15, 10 months ago GENFIT : Résultats financiers du premier trimestre 2025 Trésorerie Royalties GENFIT Iqirvo® Phase Clinique
Published on 03/23/2026 at 13:05, 34 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 1 hour 7 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 1 hour 9 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 12:30, 1 hour 9 minutes ago High Tide Resources Announces Closing of Concurrent Non-Brokered Private Placements for Gross Proceeds of $8.3 Million
Published on 03/23/2026 at 12:20, 1 hour 19 minutes ago Guanajuato Silver Adds Veteran Mine Operator to Board of Directors
Published on 03/23/2026 at 12:40, 59 minutes ago EQS-Adhoc: Ströer plans a dividend of €1.85 for fiscal year 2025 and approves a share buyback program of up to €50 million
Published on 03/23/2026 at 08:10, 5 hours 29 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 18 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 18 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 19 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 19 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
